Hester Biosciences Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Hester Biosciences Limited cash flow conversion efficiency. Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs174.78 Million ≈ $1.89 Million USD) by net assets (Rs3.51 Billion ≈ $37.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hester Biosciences Limited (2006–2025)

Cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Hester Biosciences Limited stock price today for real-time trading data and today's change.

Hester Biosciences Limited Cash Flow Conversion Ratio Explained

Hester Biosciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency. Also see HESTERBIO stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
KIP Real Estate Investment Trust KLSE:5280	0.021x
Peninsula Group Ltd TA:PEN	-0.033x
Taisun Enterprise Co Ltd TW:1218	-0.005x
Gamania Digital Entertainment Co Ltd TWO:6180	0.005x
Hanjin Transportation Co. Ltd. KO:002320	0.031x
Jeju Bank KO:006220	0.474x
SuperX AI Technology Limited NASDAQ:SUPX	-0.176x
Pitanium Ltd NASDAQ:PTNM	-0.006x

Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. Review HESTERBIO free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs3.27 Billion ≈ $35.33 Million	Rs645.11 Million ≈ $6.98 Million	0.197x	+24.27%
2024-03-31	Rs3.03 Billion ≈ $32.75 Million	Rs481.34 Million ≈ $5.21 Million	0.159x	+96.92%
2023-03-31	Rs2.92 Billion ≈ $31.62 Million	Rs235.96 Million ≈ $2.55 Million	0.081x	+145.00%
2022-03-31	Rs2.67 Billion ≈ $28.92 Million	Rs88.08 Million ≈ $952.55K	0.033x	-86.61%
2021-03-31	Rs2.36 Billion ≈ $25.52 Million	Rs580.53 Million ≈ $6.28 Million	0.246x	+32.67%
2020-03-31	Rs2.06 Billion ≈ $22.33 Million	Rs382.92 Million ≈ $4.14 Million	0.185x	-30.32%
2019-03-31	Rs1.81 Billion ≈ $19.59 Million	Rs482.10 Million ≈ $5.21 Million	0.266x	+1.48%
2018-03-31	Rs1.45 Billion ≈ $15.68 Million	Rs380.24 Million ≈ $4.11 Million	0.262x	-6.41%
2017-03-31	Rs1.24 Billion ≈ $13.43 Million	Rs347.98 Million ≈ $3.76 Million	0.280x	+51.04%
2016-03-31	Rs1.05 Billion ≈ $11.34 Million	Rs194.44 Million ≈ $2.10 Million	0.186x	-34.69%
2015-03-31	Rs838.58 Million ≈ $9.07 Million	Rs238.21 Million ≈ $2.58 Million	0.284x	+129.46%
2014-03-31	Rs762.88 Million ≈ $8.25 Million	Rs94.44 Million ≈ $1.02 Million	0.124x	-26.51%
2013-03-31	Rs684.95 Million ≈ $7.41 Million	Rs115.37 Million ≈ $1.25 Million	0.168x	-27.37%
2012-03-31	Rs610.60 Million ≈ $6.60 Million	Rs141.61 Million ≈ $1.53 Million	0.232x	-14.56%
2011-03-31	Rs479.85 Million ≈ $5.19 Million	Rs130.26 Million ≈ $1.41 Million	0.271x	-18.64%
2010-03-31	Rs408.64 Million ≈ $4.42 Million	Rs136.33 Million ≈ $1.47 Million	0.334x	+57.34%
2009-03-31	Rs366.47 Million ≈ $3.96 Million	Rs77.71 Million ≈ $840.36K	0.212x	-27.97%
2008-03-31	Rs334.69 Million ≈ $3.62 Million	Rs98.53 Million ≈ $1.07 Million	0.294x	-30.04%
2007-03-31	Rs279.47 Million ≈ $3.02 Million	Rs117.60 Million ≈ $1.27 Million	0.421x	+225.91%
2006-03-31	Rs136.48 Million ≈ $1.48 Million	Rs17.62 Million ≈ $190.56K	0.129x	--

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic

Market Cap

$208.11 Million

Rs19.24 Billion INR

Market Cap Rank

#16173 Global

#827 in India

Share Price

Rs2262.10

Change (1 day)

-0.73%

52-Week Range

Rs1259.10 - Rs2545.00

All Time High

Rs3204.96